2024

1. Alcohol Triggers the Accumulation of Oxidatively Damaged Proteins in Neuronal Cells and Tissues

   Antioxidants, Vol. 13, Núm. 5

2. Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus

   Lupus Science and Medicine, Vol. 11, Núm. 1

3. Anticoagulant and non-anticoagulant therapy in thrombotic antiphospholipid syndrome: old drugs and new treatment targets

   Rheumatology (United Kingdom), Vol. 63, Núm. SI, pp. SI96-SI106

4. Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus

   Expert Review of Clinical Immunology, Vol. 20, Núm. 4, pp. 359-373

5. Conformation- and activation-based BRET sensors differentially report on GPCR-G protein coupling

   Science signaling, Vol. 17, Núm. 841, pp. eadi4747

6. Effect of antipsychotic drugs on group II metabotropic glutamate receptor expression and epigenetic control in postmortem brains of schizophrenia subjects

   Translational Psychiatry, Vol. 14, Núm. 1

7. Effects of cannabidiol in post-stroke mood disorders in neonatal rats

   Pediatric Research, Vol. 95, Núm. 7, pp. 1783-1790

8. Efficacy and safety of long-acting injectable versus oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis

   Therapeutic Advances in Psychopharmacology, Vol. 14

9. Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study

   European Neuropsychopharmacology, Vol. 85, pp. 66-77

10. Exploring the reactivity of bicyclic α-iminophosphonates to access new imidazoline I2 receptor ligands

    Bioorganic Chemistry, Vol. 142

11. G protein-specific mechanisms in the serotonin 5-HT2A receptor regulate psychosis-related effects and memory deficits

    Nature communications, Vol. 15, Núm. 1, pp. 4307

12. High number of mitochondrial DNA alterations in postmortem brain tissue of patients with schizophrenia compared to healthy controls

    Psychiatry Research, Vol. 337

13. In need of a specific antibody against the oxytocin receptor for neuropsychiatric research: A KO validation study

    Journal of Psychiatric Research, Vol. 173, pp. 260-270

14. Is it safe to withdraw low-dose glucocorticoids in SLE patients in remission?

    Autoimmunity Reviews, Vol. 23, Núm. 1

15. Ligand bias and inverse agonism on 5-HT2A receptor-mediated modulation of G protein activity in post-mortem human brain

    British Journal of Pharmacology

16. Methylprednisolone Pulses and Prolonged Remission in Systemic Lupus Erythematosus: A Propensity Score Analysis of the Longitudinal Lupus-Cruces-Bordeaux Inception Cohort

    Arthritis Care and Research, Vol. 76, Núm. 8, pp. 1132-1138

17. NRN1 epistasis with BDNF and CACNA1C: mediation effects on symptom severity through neuroanatomical changes in schizophrenia

    Brain Structure and Function, Vol. 229, Núm. 5, pp. 1299-1315

18. Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study

    Spanish Journal of Psychiatry and Mental Health

19. New Origins of Yeast, Plant and Bacterial-Derived Extracellular Vesicles to Expand and Advance Compound Delivery

    International Journal of Molecular Sciences, Vol. 25, Núm. 13

20. Next-Generation Proteomics of Brain Extracellular Vesicles in Schizophrenia Provide New Clues on the Altered Molecular Connectome

    Biomedicines, Vol. 12, Núm. 1